Dosage form: solution/ drops
Ingredients: NAPHAZOLINE HYDROCHLORIDE 12mg in 100mL
Labeler: Sato Pharmaceutical Co., Ltd.
NDC Code: 49873-044
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Naphazoline hydrochloride 0.012%
Naphazoline hydrochloride Vasoconstrictor
Uses relieves this symptom due to minor eye irritations
■ redness of the eye
For external use only
Do not use
- if solution changes color or becomes cloudy
Ask a doctor before use if you have
- narrow angle glaucoma
When using this product
- pupils may become enlarged temporarily
- overuse of this product may produce increased redness of the eyes
- to avoid contamination, do not touch tip of container to any surface
- replace cap after using
Stop use and ask a doctor if you experience
- eye pain
- changes in vision
- continued redness or irritation of the eye
- the condition worsens or persists for more than 72 hours
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
■ Place 1 or 2 drops in the affected eyes up to 4 times daily.
- use only if imprinted tamper-resistant seal on the bottle cap is intact
- keep container tightly closed
Inactive ingredients benzalkonium chloride, boric acid, dl-camphor, sodium borate, sodium chloride, purified water.
naphazoline hydrochloride solution/ drops
|Labeler - Sato Pharmaceutical Co., Ltd. (690575642)|
|Sato Pharmaceutical Co., Ltd.||715699133||manufacture(49873-044), label(49873-044), pack(49873-044)|
Medically reviewed on Feb 13, 2019
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about naphazoline ophthalmic
- Naphazoline ophthalmic Side Effects
- Drug Interactions
- Compare Alternatives
- En Español
- Drug class: ophthalmic antihistamines and decongestants
- FDA Alerts (1)
- Naphazoline Hydrochloride (AHFS Monograph)
- Naphazoline (FDA)
- Naphazoline (Ophthalmic) (Wolters Kluwer)